These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 582007
1. Microfluorometric investigations on the cell cycle progression of experimental ascites tumors treated with alkaloidic drugs. Stöhr M, Fischinger W. Arzneimittelforschung; 1978; 28(6):977-81. PubMed ID: 582007 [Abstract] [Full Text] [Related]
2. Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-C. Hromas RA, Markel DE, Scholes VE. Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):365-8. PubMed ID: 7444164 [Abstract] [Full Text] [Related]
3. [Antitumor activity of cis-dichlorodiammineplatinum(II) and its effect on cell cycle progression]. Takahashi K, Ebihara K, Honda Y, Nishikawa K, Kita M, Oomura M, Shibasaki C. Gan To Kagaku Ryoho; 1982 Apr; 9(4):624-31. PubMed ID: 6892196 [Abstract] [Full Text] [Related]
4. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas. Houghton JA, Williams LG, Torrance PM, Houghton PJ. Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363 [Abstract] [Full Text] [Related]
5. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents. Müller LJ, Moorer-van Delft CM, Zijl R, Roubos EW. Cancer Res; 1990 Mar 15; 50(6):1924-8. PubMed ID: 2407348 [Abstract] [Full Text] [Related]
8. Characterization of the pharmacological antitumor effects of S 12363, a new vinca alkaloid. Atassi G, Berlion M, el Oche Y, Bizzari JP. Anticancer Res; 1991 Mar 15; 11(2):975-80. PubMed ID: 2064354 [Abstract] [Full Text] [Related]
10. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors. Ono M, Tanaka N. In Vivo; 1997 Mar 15; 11(3):233-41. PubMed ID: 9239517 [Abstract] [Full Text] [Related]
11. Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture. Sweeney MJ, Boder GB, Cullinan GJ, Culp HW, Daniels WD, Dyke RW, Gerzon K, McMahon RE, Nelson RL, Poore GA, Todd GC. Cancer Res; 1978 Sep 15; 38(9):2886-91. PubMed ID: 679195 [No Abstract] [Full Text] [Related]
12. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids. Shohat B, Schlesinger M, Grossowicz N, Lichtenstein N. Isr J Med Sci; 1972 Jan 15; 8(1):29-33. PubMed ID: 5067528 [No Abstract] [Full Text] [Related]
14. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity. Gan PP, Kavallaris M. Cancer Res; 2008 Dec 01; 68(23):9817-24. PubMed ID: 19047161 [Abstract] [Full Text] [Related]
15. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines. Tsuruo T, Yusa K, Sudo Y, Takamori R, Sugimoto Y. Cancer Res; 1989 Oct 15; 49(20):5537-42. PubMed ID: 2790778 [Abstract] [Full Text] [Related]
18. [Acceleration of growth of transplantable tumors and change in the sensitivity to chemotherapy on administration of creatinine]. Pukhal'skaia ECh, Platonova GN. Biull Eksp Biol Med; 1971 Oct 15; 72(10):82-5. PubMed ID: 5126158 [No Abstract] [Full Text] [Related]
19. Block of axoplasmic transport in vitro by vinca alkaloids. Chan SY, Worth R, Ochs S. J Neurobiol; 1980 May 15; 11(3):251-64. PubMed ID: 6156229 [Abstract] [Full Text] [Related]